Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. ONC

Market Cap: $37.03B

BA

BeOne Medicines AG

ONC
NASDAQUSD
Purchase ONC
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability
Gross Profit Margin87.82%
EBITDA Margin17.86%
EBIT Margin15.68%
Pre-tax Margin14.15%
Net Profit Margin10.68%
Earnings Yield1.23%
Valuation Multiples
Price / Book10.35
Price / Sales6.27
Price / Earnings24.66
PEG-0.40
Forward PEG0.68
EV / Sales5.63
EV / EBITDA31.52
EV / Operating Cash Flow23.23
EV / Free Cash Flow26.31
Price / Free Cash Flow29.31
Price / Operating Cash Flow35.89
Cash Flow & Capital
Free Cash Flow / Share$11.81
Operating Cash Flow / Share$13.37
Free Cash Flow Yield3.41%
Capex / Revenue2.84%
Capex / Operating Cash Flow11.71%
Capex / Depreciation1.12
Stock Compensation / Revenue8.53%
Dividend Payout Ratio0.00%
Dividend Yield0.00%
Liquidity & Leverage
Current Ratio3.40
Quick Ratio3.06
Cash Ratio2.41
Debt / Assets0.12
Debt / Capital0.18
Debt / Equity0.22
Long-Term Debt / Capital0.15
Debt / Market Cap2.78%
Net Debt / EBITDA-3.60
Solvency Ratio0.20
Financial Leverage1.77
Efficiency & Working Capital
Asset Turnover0.67
Fixed Asset Turnover3.43
Inventory Turnover1.02
Receivables Turnover5.75
Payables Turnover1.60
Days Sales Outstanding63.47
Days Inventory Outstanding356.38
Days Payables Outstanding228.78
Operating Cycle419.85
Cash Conversion Cycle191.07
Working Capital Turnover1.24
Returns & Quality
Return on Equity14.27%
Return on Assets7.17%
Return on Invested Capital9.63%
ROCE13.14%
Return on Tangible Assets7.22%
Operating Return on Assets10.44%
Income Quality2.27
Tax Burden0.75
Interest Burden0.90
Balance Sheet & Intrinsic Metrics
Enterprise Value$34.66B
Invested Capital$6.95B
Working Capital$5.1B
Tangible Asset Value$5.11B
Net Current Asset Value$3.21B
Graham Number$6.03
Graham Net-Net$20.31
Book Value / Share$46.37
Tangible Book Value / Share$45.83
Cash / Share$45.69
Financial Health Scores
Piotroski Score6
Altman Z-Score6.06
Revenue$6.13B
EBIT$1B
Market Cap$37.07B
Working Capital$5.1B
Retained Earnings$-7.86B
Total Assets$9.18B
Total Liabilities$4B